1-3 of 3
Daniele Perego
Close
Sort by
Journal Articles

Insulin-Like Growth Factor Binding Protein-3 (IGFBP3) Gene Expression In Myeloma Cell Lines and Patients

Alessandra Perego, Prerna Tewari, Mark Lawler, Paul Browne, Stephen Drain, Mark Catherwood, Giuseppe Limonta, Daniele Perego, Manuela Carrera, Enrico Maria Pogliani, MD
Journal: Blood
Blood (2010) 116 (21): 2489.
https://doi.org/10.1182/blood.V116.21.2489.2489
Published: 2010
Journal Articles

Low Efficacy of Thalidomide in Improving Response after Induction in Myeloma Patients Candidate to High-Dose Therapy.

Alessandro Corso, MD, Silvia Mangiacavalli, MD, Luciana Barbarano, MD, Patrizia Zappasodi, MD, Luciano Banfi, MD, Luigi Montalbetti, MD, Antonio Mazzone, MD, Sergio Fava, MD, Guido Frigerio, MD, Luciano Isa, MD, Sergio Montanara, MD, Daniele Perego, MD, Maria SavareĢ€, MD, Lilj Uziel, MD, Alessandro Vismara, MD, Leonardo Campiotti, MD, Mario FiumanoĢ€, MD, Mario Lazzarino, MD, Enrica Morra, MD
Journal: Blood
Blood (2006) 108 (11): 3567.
https://doi.org/10.1182/blood.V108.11.3567.3567
Published: 2006
Journal Articles

The Risk of Progression in 127 Early Stage CLL Patients. Prognostic Significance of Mutational Status, ZAP-70 and CD-38.

Alessandra Perego, MD, Fausto Rossini, MD, Daniele Perego, MD, Andrea Soccodato, MD, Pierluigi Tramacere, MD, Chiara Colombo, Fabio Rossi, MD, Tiziana Speranza, Paolo Mocarelli, MD, Enrico Maria Pogliani, MD
Journal: Blood
Blood (2006) 108 (11): 4937.
https://doi.org/10.1182/blood.V108.11.4937.4937
Published: 2006